← All Sponsors
SPONSOR

ModeX Therapeutics, An OPKO Health Company

Total Trials
1
Recruiting
1
Phases
Phase 1, Phase 2
Conditions studied: LymphomaWaldenström Macroglobulinemia (WM)DLBCL - Diffuse Large B Cell LymphomaPMBCLHGBCLFL LymphomaLymphoplasmacytic LymphomaFollicular Lymphoma (FL)
NCT07249905 Phase 1, Phase 2
Recruiting

Dose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of Lymphoma

Lymphoma
Australia View Trial →